Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Liabilities and Shareholders Equity (2016 - 2025)

Arcadia Biosciences filings provide 12 years of Liabilities and Shareholders Equity readings, the most recent being $6.5 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 51.57% to $6.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $35.9 million, a 42.25% decrease, with the full-year FY2025 number at $6.5 million, down 51.57% from a year prior.
  • Liabilities and Shareholders Equity hit $6.5 million in Q4 2025 for Arcadia Biosciences, down from $8.6 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $70.8 million in Q1 2021 to a low of $6.5 million in Q4 2025.
  • Median Liabilities and Shareholders Equity over the past 5 years was $25.1 million (2023), compared with a mean of $29.0 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: surged 119.55% in 2021 and later plummeted 55.16% in 2025.
  • Arcadia Biosciences' Liabilities and Shareholders Equity stood at $43.9 million in 2021, then tumbled by 34.15% to $28.9 million in 2022, then tumbled by 31.87% to $19.7 million in 2023, then tumbled by 31.4% to $13.5 million in 2024, then plummeted by 51.57% to $6.5 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $6.5 million (Q4 2025), $8.6 million (Q3 2025), and $7.8 million (Q2 2025) per Business Quant data.